Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311662014> ?p ?o ?g. }
- W4311662014 endingPage "e0278950" @default.
- W4311662014 startingPage "e0278950" @default.
- W4311662014 abstract "Real world effectiveness, toxicity and costs analyses from chimeric antigen receptor (CAR)-T cell therapy are of utmost relevance to determine whether and how to offer patients highly personalized immunotherapy. In this study, we aimed at describing CAR T-cells effectiveness, safety and costs in a Portuguese Comprehensive Cancer Center. We performed a retrospective descriptive study of adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma and transformed follicular lymphoma referred to CAR T-cell therapy, between May 2019 and February 2021. Rates of treatment response, toxicity and survival (Kaplan-Meier method) were analyzed by intention-to-treat. Direct medical costs stratified by inpatient-care, outpatient-care, and diagnostic-therapeutic procedures (DTP) were derived based on resources used and their respective unit costs. In twenty patients (median age 49.5y; 55%male; 70%DLBCL; 50% with primary refractory disease), best overall and complete response rates were 65.0% and 45.0%, respectively. Median overall (OS) and progression-free survivals were 9.2 and 7.3 months; 12-month OS rate was 42.6% (95%CI:23.2-78.3). Grade≥3 cytokine release syndrome and neurotoxicity occurred in 5.6% and 11.1% of patients, respectively. CAR T-cell therapy expenditure, including adverse events costs, was 7 176 196€, or 286 238€ when excluding drug cost. Median cost for treated patient was 355 165€ with CAR T-cell drug cost accounting for 97.0% of the overall expense. Excluding CAR T-cell acquisition cost, inpatient-care and DTP accounted for 57% and 38% of total cost/patient, respectively. Our findings highlight the heavy economic burden of CAR T-cell therapy driven by drug acquisition costs." @default.
- W4311662014 created "2022-12-27" @default.
- W4311662014 creator A5012718986 @default.
- W4311662014 creator A5017676695 @default.
- W4311662014 creator A5022689428 @default.
- W4311662014 creator A5032815908 @default.
- W4311662014 creator A5034189673 @default.
- W4311662014 creator A5074370712 @default.
- W4311662014 creator A5086420818 @default.
- W4311662014 date "2022-12-09" @default.
- W4311662014 modified "2023-10-06" @default.
- W4311662014 title "Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center" @default.
- W4311662014 cites W1990602451 @default.
- W4311662014 cites W2119147717 @default.
- W4311662014 cites W2598700764 @default.
- W4311662014 cites W2773804840 @default.
- W4311662014 cites W2792588868 @default.
- W4311662014 cites W2800595080 @default.
- W4311662014 cites W2809013389 @default.
- W4311662014 cites W2903062212 @default.
- W4311662014 cites W2903225254 @default.
- W4311662014 cites W2905654445 @default.
- W4311662014 cites W2911451382 @default.
- W4311662014 cites W2944976798 @default.
- W4311662014 cites W2945048769 @default.
- W4311662014 cites W2948047060 @default.
- W4311662014 cites W2949232578 @default.
- W4311662014 cites W2969378107 @default.
- W4311662014 cites W2978959216 @default.
- W4311662014 cites W2992445625 @default.
- W4311662014 cites W3015094526 @default.
- W4311662014 cites W3018120101 @default.
- W4311662014 cites W3024978145 @default.
- W4311662014 cites W3025383904 @default.
- W4311662014 cites W3029598682 @default.
- W4311662014 cites W3043369050 @default.
- W4311662014 cites W3045009269 @default.
- W4311662014 cites W3116950401 @default.
- W4311662014 cites W3134850399 @default.
- W4311662014 cites W3154903133 @default.
- W4311662014 cites W3174028996 @default.
- W4311662014 cites W3184235241 @default.
- W4311662014 cites W3194938700 @default.
- W4311662014 cites W3199906087 @default.
- W4311662014 cites W3201013983 @default.
- W4311662014 cites W4224030133 @default.
- W4311662014 cites W4225137024 @default.
- W4311662014 cites W4281665399 @default.
- W4311662014 cites W4292309547 @default.
- W4311662014 doi "https://doi.org/10.1371/journal.pone.0278950" @default.
- W4311662014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36490296" @default.
- W4311662014 hasPublicationYear "2022" @default.
- W4311662014 type Work @default.
- W4311662014 citedByCount "1" @default.
- W4311662014 crossrefType "journal-article" @default.
- W4311662014 hasAuthorship W4311662014A5012718986 @default.
- W4311662014 hasAuthorship W4311662014A5017676695 @default.
- W4311662014 hasAuthorship W4311662014A5022689428 @default.
- W4311662014 hasAuthorship W4311662014A5032815908 @default.
- W4311662014 hasAuthorship W4311662014A5034189673 @default.
- W4311662014 hasAuthorship W4311662014A5074370712 @default.
- W4311662014 hasAuthorship W4311662014A5086420818 @default.
- W4311662014 hasBestOaLocation W43116620141 @default.
- W4311662014 hasConcept C121608353 @default.
- W4311662014 hasConcept C126322002 @default.
- W4311662014 hasConcept C143998085 @default.
- W4311662014 hasConcept C197934379 @default.
- W4311662014 hasConcept C2777058707 @default.
- W4311662014 hasConcept C2777701055 @default.
- W4311662014 hasConcept C2778559949 @default.
- W4311662014 hasConcept C2779338263 @default.
- W4311662014 hasConcept C2780850621 @default.
- W4311662014 hasConcept C3875195 @default.
- W4311662014 hasConcept C71924100 @default.
- W4311662014 hasConceptScore W4311662014C121608353 @default.
- W4311662014 hasConceptScore W4311662014C126322002 @default.
- W4311662014 hasConceptScore W4311662014C143998085 @default.
- W4311662014 hasConceptScore W4311662014C197934379 @default.
- W4311662014 hasConceptScore W4311662014C2777058707 @default.
- W4311662014 hasConceptScore W4311662014C2777701055 @default.
- W4311662014 hasConceptScore W4311662014C2778559949 @default.
- W4311662014 hasConceptScore W4311662014C2779338263 @default.
- W4311662014 hasConceptScore W4311662014C2780850621 @default.
- W4311662014 hasConceptScore W4311662014C3875195 @default.
- W4311662014 hasConceptScore W4311662014C71924100 @default.
- W4311662014 hasIssue "12" @default.
- W4311662014 hasLocation W43116620141 @default.
- W4311662014 hasLocation W43116620142 @default.
- W4311662014 hasLocation W43116620143 @default.
- W4311662014 hasLocation W43116620144 @default.
- W4311662014 hasOpenAccess W4311662014 @default.
- W4311662014 hasPrimaryLocation W43116620141 @default.
- W4311662014 hasRelatedWork W2055742427 @default.
- W4311662014 hasRelatedWork W2305384511 @default.
- W4311662014 hasRelatedWork W2916176185 @default.
- W4311662014 hasRelatedWork W2933778904 @default.
- W4311662014 hasRelatedWork W2969241243 @default.
- W4311662014 hasRelatedWork W3028202721 @default.